Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SRx Health Solutions (SRXH) Gains from Investment Securities (2017 - 2025)

SRx Health Solutions (SRXH) has disclosed Gains from Investment Securities for 9 consecutive years, with $39732.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities fell 96.92% year-over-year to $39732.0, compared with a TTM value of $39732.0 through Sep 2025, down 96.92%, and an annual FY2025 reading of $39732.0, changed N/A over the prior year.
  • Gains from Investment Securities was $39732.0 for Q3 2025 at SRx Health Solutions, down from $278000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $30.8 million in Q4 2021 and bottomed at -$29.4 million in Q2 2021.
  • Average Gains from Investment Securities over 5 years is $228702.3, with a median of $22727.0 recorded in 2024.
  • Peak annual rise in Gains from Investment Securities hit 7474.82% in 2021, while the deepest fall reached 945.02% in 2021.
  • Year by year, Gains from Investment Securities stood at $30.8 million in 2021, then crashed by 99.59% to $127000.0 in 2022, then surged by 1140.16% to $1.6 million in 2023, then crashed by 94.16% to $92000.0 in 2024, then tumbled by 56.81% to $39732.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for SRXH at $39732.0 in Q3 2025, $278000.0 in Q2 2025, and $1586.0 in Q1 2025.